✦ LIBER ✦

An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma

✍ Scribed by Peter Reichardt; Karin Oechsle; Daniel Pink; Carsten Bokemeyer; F. Schneller; Rolf Issels; Lothar Kanz; Jörg Thomas Hartmann

Book ID: 111559148
Publisher: Springer US
Year: 2003
Tongue: English
Weight: 70 KB
Volume: 21
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1026263604863

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pemetrexed in patients with refractory s

Pemetrexed in patients with refractory soft tissue sarcoma: A non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005

✍ J. T. Hartmann, S. Bauer, G. Egerer, M. S. Horger, H.-G. Kopp, V. Grünwald, F. M 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 255 KB

P-489 An open label, multicenter, non-co

P-489 An open label, multicenter, non-comparative phase II study of weekly intravenous vinorelbine (V) and topotecan (T) in chemotherapy-naive patients (pts) with advanced non-small cell lung cancer (NSCLC)

✍ Grunberg, S.; Clarkson, J.; Harper, H.; Gomolin, H.; Guthrie, T.; Bandekar, R.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Brostallicin versus doxorubicin as first

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study

✍ Gelderblom, H.; Blay, J.Y.; Seddon, B.M.; Leahy, M.; Ray-Coquard, I.; Sleijfer, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 758 KB

Randomized Phase II Study of Gemcitabine

Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002

✍ Maki, R. G.; Wathen, J. K.; Patel, S. R.; Priebat, D. A.; Okuno, S. H.; Samuels, 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 163 KB

Brostallicin, an agent with potential ac

Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: A phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

✍ Michael Leahy; Isabelle Ray-Coquard; Jaap Verweij; Axel Le Cesne; Florence Duffa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 166 KB

A phase II study of tasisulam sodium (LY

A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma

✍ Christopher W. Ryan, Chacon Matias, Mark Agulnik, Antonio Lopez-Pousa, Charles W 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 155 KB